1 study found for:    weill | Open Studies | "Paramyxoviridae Infections"
Show Display Options
Rank Status Study
1 Recruiting A Phase II, Randomized, Double-blind, Placebo-controlled Study to Examine the Effects of DAS181 in Immunocompromised Subjects With Lower Respiratory Tract Parainfluenza Infection on Supplemental Oxygen
Condition: Parainfluenza
Interventions: Drug: DAS181 dry powder, formulation F02;   Drug: Lactose Placebo

Indicates status has not been verified in more than two years